Providing Healthcare for Everyone Everywhere
Jointown Pharmaceutical Group Co., Ltd.
About Jointown
Strive to build up the most professional comprehensive health service platform in China
More billion RMB
Operating Income in 2023 billion RMB
Net Income Attributable (Excl. Excep) in 2023 billion RMB
Net Cash Flow in 2023 billion RMB
Total Assets people
Employees th
Chinese Private Enterprise th
Chinese Private Enterprise in Service Industry
Digital Pharmaceutical Distribution and Supply Chain Business
General Agency Brand Promotion Business
Pharmaceutical Industrial Self-production and OEM Business
Pharmaceutical New Retail & Ten-Thousand Store Alliance Plan Business
Medical Health and Technology Value-added Services
Digital Logistics Technology and Supply Chain SolutionsOur Businesses More
Digital Pharmaceutical Distribution and Supply Chain Business
MoreJointown is committed to providing upstream customers with full-channel and full-scenario digital distribution and promotion services, and downstream customers with "one-stop" full-variety digital supply chain services.
billion RMB
Sales Revenue in 2023 billion RMB
Gross Profit +
Youngjoin Active Users 
News Center More
Company Dynamics And Industry Information
MoreCorporate News
2023China's Top 500 Private Enterprises released! Jointown ranked 57th
On September 11th, 2023 China Top 500 Private Enterprises Summit and National Top Private Enterprises Helping Shandong Green, Low Carbon and High Quality Development Conference was held in Jinan, Shandong Province, and Liu Changyun, Chairman of the Board of Directors of Jointown, was invited to attend the event.
2024-01-31
MoreCorporate News
Developing a Technical Foundation of Digital Smart Logistics for Pharmaceutical Enterprises in the Furtherance of High-quality Development of Pharmaceutical Supply Chains
Recently, the Conference on Innovation and Development of Modern Pharmaceutical Logistics Storage Technologies, hosted by Pharmaceutical Logistics Branch of China Federation of Logistics & Purchasing, was successfully held in Xi 'an.
2024-07-31
MoreCorporate News
Jointown issued the Asset-backed Notes of 1 billion RMB, Promoting Development with Innovative Financing
On July 19, 2024, Jointown Pharmaceutical Group Co. Ltd. disclosed the issuance of the Asset-Backed Notes Series 2 in 2024 (hereinafter referred to as “the Asset-Back Notes”), with a total amount of RMB 1 billion. The coupon interest rate hit a new low among the notes of private enterprises in China with the same type and the same maturity. The issuance has broadened the finance resources of Jointown, optimized the asset structure of the Company, and reinvigorated further development.
2024-07-30
MoreCorporate News
Jointown Smart Pharmacy was Ranked among the Top 10 Pharmaceutical Retail Enterprises
The 20th Annual Conference of Chinese Retail Pharmacies and the 5th China Specialty Pharmacy Development Forum was highly profile and grandly held at the International Conference Center of Kunming Yunan Conference Resort, in Kunming, Yunnan Province. The conference was organized by the China Association of Pharmaceutical Commerce with the theme of “Lead by Professionals & Integrated with Innovation,” which attracted more than 1,000 participants, such as leaders from the Ministry of Commerce of t
2024-07-30
MoreInvestor Relations More 
Announcement
Q & A More
Stock Information
MoreJointown Pharmaceutical Group Co., Ltd. 600998.SH
4.61 
-0.03
-0.65%
2024-08-07 16:29:00Open 4.63
Previous Close 4.64
High 4.64
Low 4.54
Volume 20,933,838
Turnover 96,335,265RMB
Announcement Q & AESG
Green development and technological empowerment create a sustainable future
Oriented by Green development and driven by innovation, we promote ESG practices through digitalization to create long-term value for the sustainable development of environment and society.
MoreJointown Service Platforms
Official Account
Video Account
Jointown Base Account
In-Transit Inquiry of Goods
Jointown Healthcare Technology
INZ Tech
JPG Logistics
Youngjoin
Address: No. 5 Longxing West Street, Hanyang District, Wuhan City, Hubei Province, China | Postal code: 430051 | Consultation hotline: 4008004488 | National hotline: 4001600998 | Official email: jztdmc@mingkecnc.com
© 2016-2024 Jointown Pharmaceutical Group Co., Ltd. Hubei ICP Registration No.64409955-20 | Public Security Registration: Hubei Public Network Security Registration No. 42010502001705
Providing Healthcare for Everyone Everywhere
Jointown Pharmaceutical Group Co., Ltd.
Strive to build up the most professional comprehensive health service platform in China
billion RMB
Operating Income in 2023 billion RMB
Net Income Attributable (Excl. Excep) in 2023 billion RMB
Net Cash Flow in 2023 billion RMB
Total Assets people
Employees th
Chinese Private Enterprise th
Chinese Private Enterprise in Service Industry MoreOur Businesses
Digital Pharmaceutical Distribution and Supply Chain Business
Jointown is committed to providing upstream customers with full-channel and full-scenario digital distribution and promotion services, and downstream customers with "one-stop" full-variety digital supply chain services.
billion RMB
Sales Revenue in 2023 billion RMB
Gross Profit +
Youngjoin Active Users MoreGeneral Agency Brand Promotion Business
With its General Agency Brand Promotion (CSO) business moving into the fast lane, the Company continues to build the "second curve" for profit growth, and upgrades the brand of "ALL WAYS ENGINE".
billion RMB
Sales Revenue in 2023 MorePharmaceutical Industrial Self-production and OEM Business
Based on the existing varieties, brands, channels and marketing advantages, Jointown has conducted targeted development of self-operated industrial products and OEM business by virtue of big data accumulated by the Company's "hundred-billion-level" supply chain service platform. The business enjoys cluster development with respect to self-owned varieties.
billion RMB
Sales Revenue in 2023 +
Varieties of Drug Production MorePharmaceutical New Retail & Ten-Thousand Store Alliance Plan Business
New retail and Ten-Thousand Store Alliance Plan business is an integral part of Jointown's "Three News and Two Transformations" strategic transformation, and the core of new retail strategy. Jointown makes full use of the established supply chain advantages to empower the retailing business, reach C-end users and expand the business through the "Ten-Thousand Store Alliance Plan", "integration of wholesale and retail" and the combination of online and offline channels.
billion RMB
Sales Revenue in 2023 +
O2O Retail Stores MoreMedical Health and Technology Value-added Services
Jointown continues to carry out independent development and provides customers with information technology-driven value-added services; it also advances the development of medical diagnosis services, enhances public health service capabilities, and extends the business to medical services, health management, medical technology and other comprehensive health fields, to create a comprehensive health service platform.
million RMB
Sales Revenue in 2023 MoreDigital Logistics Technology and Supply Chain Solutions
Relying on Jointown Cloud Warehouse, Jointown expands the third-party/fourth-party business and cold chain business, providing technology output and supply chain solutions.
million RMB
Sales Revenue in 2023 MoreCompany Dynamics And Industry Information
MoreCorporate News
2023China's Top 500 Private Enterprises released! Jointown ranked 57th
On September 11th, 2023 China Top 500 Private Enterprises Summit and National Top Private Enterprises Helping Shandong Green, Low Carbon and High Quality Development Conference was held in Jinan, Shandong Province, and Liu Changyun, Chairman of the Board of Directors of Jointown, was invited to attend the event.
2024-01-31
Corporate News
Developing a Technical Foundation of Digital Smart Logistics for Pharmaceutical Enterprises in the Furtherance of High-quality Development of Pharmaceutical Supply Chains
Recently, the Conference on Innovation and Development of Modern Pharmaceutical Logistics Storage Technologies, hosted by Pharmaceutical Logistics Branch of China Federation of Logistics & Purchasing, was successfully held in Xi 'an.
2024-07-31
Corporate News
Jointown issued the Asset-backed Notes of 1 billion RMB, Promoting Development with Innovative Financing
On July 19, 2024, Jointown Pharmaceutical Group Co. Ltd. disclosed the issuance of the Asset-Backed Notes Series 2 in 2024 (hereinafter referred to as “the Asset-Back Notes”), with a total amount of RMB 1 billion. The coupon interest rate hit a new low among the notes of private enterprises in China with the same type and the same maturity. The issuance has broadened the finance resources of Jointown, optimized the asset structure of the Company, and reinvigorated further development.
2024-07-30
Corporate News
Jointown Smart Pharmacy was Ranked among the Top 10 Pharmaceutical Retail Enterprises
The 20th Annual Conference of Chinese Retail Pharmacies and the 5th China Specialty Pharmacy Development Forum was highly profile and grandly held at the International Conference Center of Kunming Yunan Conference Resort, in Kunming, Yunnan Province. The conference was organized by the China Association of Pharmaceutical Commerce with the theme of “Lead by Professionals & Integrated with Innovation,” which attracted more than 1,000 participants, such as leaders from the Ministry of Commerce of t
2024-07-30
Stock Information
MoreJointown Pharmaceutical Group Co., Ltd. 
Announcement
Q & A
600998.SH
4.61
Open 4.63
Previous Close 4.64
Volume 20,933,838
2024-08-07 16:29:00
-0.03
-0.65%
High 4.64
Low 4.54
Turnover 96,335,265RMB
Announcement Q & AGreen development and technological empowerment create a sustainable future
Oriented by Green development and driven by innovation, we promote ESG practices through digitalization to create long-term value for the sustainable development of environment and society.
MoreJointown Service Platforms
Official Account Video Account Jointown Base Account In-Transit Inquiry of GoodsAddress: No. 5 Longxing West Street, Hanyang District, Wuhan City, Hubei Province, China | Postal code: 430051 | Consultation hotline: 4008004488 | National hotline: 4001600998 | Official email: jztdmc@mingkecnc.com
© 2016-2024 Jointown Pharmaceutical Group Co., Ltd. Hubei ICP Registration No.64409955-20 | Public Security Registration: Hubei Public Network Security Registration No. 42010502001705